What is insider trading data?

Insider trading data comes from SEC Form 4 filings, which corporate insiders must file within 2 business days of buying or selling company stock. This includes CEOs, CFOs, directors, and major shareholders.

How do I track congressional stock trades?

InsiderStreet.ai aggregates financial disclosures from the STOCK Act, showing stock trades by members of Congress. These are typically disclosed within 45 days of the transaction.

What are 13F filings?

13F filings are quarterly reports that institutional investment managers with over $100 million in assets must file with the SEC, revealing their equity holdings.

Financial News — InsiderStreet

📰

Precigen expects Q1 revenue to exceed $18M as PAPZIMEOS launch accelerates with broad U.S. payer coverage

bullish PGEN SeekingAlpha 14h ago

📰

Cytosorbents outlines cash flow breakeven path for second half of 2026 amid international sales growth

bullish CTSO SeekingAlpha 14h ago

📰

POMDOCTOR CLASS ACTION ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against PomDoctor, Ltd. and Encourages Stockholders to Contact the Firm

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In PomDoctor (POM) To Contact Him Directly...

bearish POM Benzinga-News 14h ago

📰

AtlanTech Vision Files Provisional Patent for PVD™ HemiComb™ - Minimalist Glasses-Free Light-Field Displays

AtlanTech Vision Corporation (ATVICO) today announced the successful filing of a U.S. Provisional Patent Application for its groundbreaking PVD™...

bullish CON PRNewswire 14h ago

📰

Palvella Stock Up 340% as Insider Sells Shares. Here's What the Move Does (And Does Not) Signal

This clinical-stage biotech advancing therapies for rare skin diseases reported a notable insider sale amid a year of sharp stock gains.

bearish PVLA MotleyFool 14h ago

📰

ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Nektar Therapeutics Investors to Secure Counsel Before Important Deadline in Securities Class Action - NKTR

neutral NKTR Benzinga-News 14h ago

Draganfly Stock Sheds 21% Post-Earnings — Here's Why It's Still A Buy

Shares of drone tech company Draganfly Inc. (NASDAQ:DPRO) sold off hard on Wednesday after disappointing fourth-quarter earnings — but the report and...

bullish TECH Benzinga-News 14h ago

📰

MREO FINAL DEADLINE: ROSEN, LEADING TRIAL ATTORNEYS, Encourages Mereo BioPharma Group plc Investors to Secure Counsel Before Important April 6 Deadline in Securities Class Action – MREO

neutral MREO Benzinga-News 14h ago

📰

Why Medpace (MEDP) Outpaced the Stock Market Today

In the closing of the recent trading day, Medpace (MEDP) stood at $466.8, denoting a +1.32% move from the preceding trading day.

bullish MEDP Zacks 14h ago

📰

ROSEN, HIGHLY REGARDED INVESTOR RIGHTS COUNSEL, Encourages Soleno Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – SLNO

neutral SLNO Benzinga-News 14h ago

📰

Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Inovio Pharmaceuticals, Inc. and Encourages Investors to Contact the Firm

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Inovio (INO) To Contact Him Directly To...

neutral INO Benzinga-News 14h ago

📰

Dyadic (DYAI) Q4 2025 Earnings Call Transcript

Image source: The Motley Fool.Wednesday, March 25, 2026 at 5 p.m. ETNeed a quote from a Motley Fool analyst? Email pr@fool.comContinue reading

neutral DYAI MotleyFool 15h ago

📰

Here are the major earnings before the open Thursday

neutral HYPD SeekingAlpha 15h ago

📰

Here are the major earnings before the open Thursday

neutral PAVM SeekingAlpha 15h ago

📰

Here are the major earnings before the open Thursday

neutral RMTI SeekingAlpha 15h ago

📰

Oscar Health, Inc. (OSCR) Outpaces Stock Market Gains: What You Should Know

Oscar Health, Inc. (OSCR) concluded the recent trading session at $12.21, signifying a +1.5% move from its prior day's close.

bullish OSCR Zacks 15h ago

📰

Is Pfizer Stock a Buy After This Win?

Good news has been scarce for this beaten-down drugmaker.

bullish PFE MotleyFool 15h ago

📰

Tivic Health outlines $20B oncology market opportunity following strategic transformation

bullish TIVC SeekingAlpha 15h ago

📰

Vertex Pharmaceuticals (VRTX) Laps the Stock Market: Here's Why

Vertex Pharmaceuticals (VRTX) concluded the recent trading session at $454.97, signifying a +1.42% move from its prior day's close.

bullish VRTX Zacks 15h ago

📰

Amgen (AMGN) Outpaces Stock Market Gains: What You Should Know

In the most recent trading session, Amgen (AMGN) closed at $353.93, indicating a +1.58% shift from the previous trading day.

bullish AMGN Zacks 15h ago

📰

Why CRISPR Therapeutics AG (CRSP) Outpaced the Stock Market Today

CRISPR Therapeutics AG (CRSP) closed the most recent trading day at $47.09, moving +1.42% from the previous trading session.

bullish CRSP Zacks 15h ago

📰

Adma Biologics (ADMA) Stock Slides as Market Rises: Facts to Know Before You Trade

Adma Biologics (ADMA) closed the most recent trading day at $9.63, moving 15% from the previous trading session.

bearish ADMA Zacks 15h ago

📰

Eli Lilly (LLY) Outpaces Stock Market Gains: What You Should Know

The latest trading day saw Eli Lilly (LLY) settling at $916.31, representing a +1.47% change from its previous close.

bullish LLY Zacks 15h ago

📰

Johnson & Johnson (JNJ) Surpasses Market Returns: Some Facts Worth Knowing

Johnson & Johnson (JNJ) closed the most recent trading day at $239.93, moving +1.98% from the previous trading session.

bullish JNJ Zacks 15h ago

📰

Bristol Myers Squibb (BMY) Surpasses Market Returns: Some Facts Worth Knowing

In the closing of the recent trading day, Bristol Myers Squibb (BMY) stood at $58.94, denoting a +2.7% move from the preceding trading day.

bullish BMY Zacks 15h ago

📰

Novo Nordisk (NVO) Stock Slides as Market Rises: Facts to Know Before You Trade

Novo Nordisk (NVO) closed the most recent trading day at $36.33, moving 1.52% from the previous trading session.

bearish NVO Zacks 15h ago

📰

Dare Bioscience FY 2025 Earnings Preview

neutral DARE SeekingAlpha 15h ago

📰

Insight Molecular Diagnostics Inc. Q4 2025 Earnings Preview

neutral IMDX SeekingAlpha 15h ago

📰

Precigen, Inc. (PGEN) Reports Q4 Loss, Lags Revenue Estimates

Precigen (PGEN) delivered earnings and revenue surprises of +89.47% and -17.45%, respectively, for the quarter ended December 2025. Do the numbers...

bearish NRIX Zacks 15h ago

📰

Precigen, Inc. (PGEN) Reports Q4 Loss, Lags Revenue Estimates

Precigen (PGEN) delivered earnings and revenue surprises of +89.47% and -17.45%, respectively, for the quarter ended December 2025. Do the numbers...

bearish PGEN Zacks 15h ago

Atossa Therapeutics Reports Fourth Quarter and Year-End 2025 Financial Results and Provides a Corporate Update

SEATTLE, March 25, 2026 /PRNewswire/ -- Atossa Therapeutics, Inc. (NASDAQ:ATOS) (Atossa or the Company), a clinical-stage biopharmaceutical company...

neutral ATOS Benzinga-Earnings 15h ago

Atossa Therapeutics Reports Fourth Quarter and Year-End 2025 Financial Results and Provides a Corporate Update

SEATTLE, March 25, 2026 /PRNewswire/ -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) (Atossa or the Company), a clinical-stage biopharmaceutical company...

neutral ATOS PRNewswire 15h ago

📰